APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acrivastine Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acrivastine Capsules Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchAcrivastine Capsules Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acrivastine Capsules Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Acrivastine Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acrivastine Capsules Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Acrivastine Capsules Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Acrivastine Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acrivastine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acrivastine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acrivastine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acrivastine Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acrivastine Capsules market include Actient Pharmaceuticals, Benadryl, Brown & Burk UK, McNeil Laboratories, The Wellcome Foundation and Chongqing Huapont Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Acrivastine Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acrivastine Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acrivastine Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acrivastine Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Acrivastine Capsules Segment by Company

Actient Pharmaceuticals

Benadryl

Brown & Burk UK

McNeil Laboratories

The Wellcome Foundation

Chongqing Huapont Pharmaceutical

Acrivastine Capsules Segment by Type

24 Capsules/Box

20 Capsules/Box

12 Capsules/Box

Acrivastine Capsules Segment by Application

Hospital

Clinic

Acrivastine Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Acrivastine Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Acrivastine Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acrivastine Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Acrivastine Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acrivastine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acrivastine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acrivastine Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Acrivastine Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acrivastine Capsules industry.

Chapter 3: Detailed analysis of Acrivastine Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Acrivastine Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Acrivastine Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acrivastine Capsules Industry Trends Table 2. Acrivastine Capsules Industry Drivers Table 3. Acrivastine Capsules Industry Opportunities and Challenges Table 4. Acrivastine Capsules Industry Restraints Table 5. Global Acrivastine Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acrivastine Capsules Revenue Share by Company (2021-2026) Table 7. Global Acrivastine Capsules Sales Volume by Company (k units) & (2021-2026) Table 8. Global Acrivastine Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Acrivastine Capsules Average Price (US$/unit) of Company (2021-2026) Table 10. Global Acrivastine Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Acrivastine Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Acrivastine Capsules Company, Product Type & Application Table 13. Global Acrivastine Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Acrivastine Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 24 Capsules/Box Table 18. Significant Companies of 20 Capsules/Box Table 19. Significant Companies of 12 Capsules/Box Table 20. Global Acrivastine Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Acrivastine Capsules Sales Volume by Type (2021-2026) & (k units) Table 22. Global Acrivastine Capsules Sales Volume by Type (2027-2032) & (k units) Table 23. Global Acrivastine Capsules Sales Volume Share by Type (2021-2026) Table 24. Global Acrivastine Capsules Sales Volume Share by Type (2027-2032) Table 25. Global Acrivastine Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Acrivastine Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Acrivastine Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Acrivastine Capsules Sales Value Share by Type (2021-2026) Table 29. Global Acrivastine Capsules Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Global Acrivastine Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Acrivastine Capsules Sales Volume by Application (2021-2026) & (k units) Table 34. Global Acrivastine Capsules Sales Volume by Application (2027-2032) & (k units) Table 35. Global Acrivastine Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Acrivastine Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Acrivastine Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Acrivastine Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Acrivastine Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Acrivastine Capsules Sales Value Share by Application (2021-2026) Table 41. Global Acrivastine Capsules Sales Value Share by Application (2027-2032) Table 42. Global Acrivastine Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Acrivastine Capsules Sales by Region (2021-2026) & (k units) Table 44. Global Acrivastine Capsules Sales Market Share by Region (2021-2026) Table 45. Global Acrivastine Capsules Sales by Region (2027-2032) & (k units) Table 46. Global Acrivastine Capsules Sales Market Share by Region (2027-2032) Table 47. Global Acrivastine Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Acrivastine Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Acrivastine Capsules Sales Value Share by Region (2021-2026) Table 50. Global Acrivastine Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Acrivastine Capsules Sales Value Share by Region (2027-2032) Table 52. Global Acrivastine Capsules Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Acrivastine Capsules Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Acrivastine Capsules Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Acrivastine Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Acrivastine Capsules Sales by Country (2021-2026) & (k units) Table 57. Global Acrivastine Capsules Sales Market Share by Country (2021-2026) Table 58. Global Acrivastine Capsules Sales by Country (2027-2032) & (k units) Table 59. Global Acrivastine Capsules Sales Market Share by Country (2027-2032) Table 60. Global Acrivastine Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Acrivastine Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Acrivastine Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Acrivastine Capsules Sales Value Market Share by Country (2027-2032) Table 64. Actient Pharmaceuticals Company Information Table 65. Actient Pharmaceuticals Business Overview Table 66. Actient Pharmaceuticals Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Actient Pharmaceuticals Acrivastine Capsules Product Portfolio Table 68. Actient Pharmaceuticals Recent Development Table 69. Benadryl Company Information Table 70. Benadryl Business Overview Table 71. Benadryl Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Benadryl Acrivastine Capsules Product Portfolio Table 73. Benadryl Recent Development Table 74. Brown & Burk UK Company Information Table 75. Brown & Burk UK Business Overview Table 76. Brown & Burk UK Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Brown & Burk UK Acrivastine Capsules Product Portfolio Table 78. Brown & Burk UK Recent Development Table 79. McNeil Laboratories Company Information Table 80. McNeil Laboratories Business Overview Table 81. McNeil Laboratories Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. McNeil Laboratories Acrivastine Capsules Product Portfolio Table 83. McNeil Laboratories Recent Development Table 84. The Wellcome Foundation Company Information Table 85. The Wellcome Foundation Business Overview Table 86. The Wellcome Foundation Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. The Wellcome Foundation Acrivastine Capsules Product Portfolio Table 88. The Wellcome Foundation Recent Development Table 89. Chongqing Huapont Pharmaceutical Company Information Table 90. Chongqing Huapont Pharmaceutical Business Overview Table 91. Chongqing Huapont Pharmaceutical Acrivastine Capsules Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Chongqing Huapont Pharmaceutical Acrivastine Capsules Product Portfolio Table 93. Chongqing Huapont Pharmaceutical Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Acrivastine Capsules Distributors List Table 97. Acrivastine Capsules Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Acrivastine Capsules Product Image Figure 2. Global Acrivastine Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Acrivastine Capsules Sales (2021-2032) & (k units) Figure 5. Global Acrivastine Capsules Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Acrivastine Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 24 Capsules/Box Image Figure 10. 20 Capsules/Box Image Figure 11. 12 Capsules/Box Image Figure 12. Global Acrivastine Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Acrivastine Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Acrivastine Capsules Sales Volume Share by Type (2021-2032) Figure 15. Global Acrivastine Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Acrivastine Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Acrivastine Capsules Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Acrivastine Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Acrivastine Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Acrivastine Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Acrivastine Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Acrivastine Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Acrivastine Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Acrivastine Capsules Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Acrivastine Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Acrivastine Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Acrivastine Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Acrivastine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Acrivastine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Acrivastine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Acrivastine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Acrivastine Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Acrivastine Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Acrivastine Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Acrivastine Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Acrivastine Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 24 Capsules/Box
  • 20 Capsules/Box
  • 12 Capsules/Box
Applications
  • Hospital
  • Clinic
Companies covered
  • Actient Pharmaceuticals
  • Benadryl
  • Brown & Burk UK
  • McNeil Laboratories
  • The Wellcome Foundation
  • Chongqing Huapont Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acrivastine Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Acrivastine Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Acrivastine Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Acrivastine Capsules Market Dynamics
  1. 2.1 Acrivastine Capsules Industry Trends
  2. 2.2 Acrivastine Capsules Industry Drivers
  3. 2.3 Acrivastine Capsules Industry Opportunities and Challenges
  4. 2.4 Acrivastine Capsules Industry Restraints
3 Acrivastine Capsules Market by Company
  1. 3.1 Global Acrivastine Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Acrivastine Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Acrivastine Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Acrivastine Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Acrivastine Capsules Company Ranking (2024-2026)
  6. 3.6 Global Acrivastine Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Acrivastine Capsules Company Product Type and Application
  8. 3.8 Global Acrivastine Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Acrivastine Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Acrivastine Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Acrivastine Capsules Market by Type
  1. 4.1 Acrivastine Capsules Type Introduction
  2. 4.1.1 24 Capsules/Box
  3. 4.1.2 20 Capsules/Box
  4. 4.1.3 12 Capsules/Box
  5. 4.2 Global Acrivastine Capsules Sales Volume by Type
  6. 4.2.1 Global Acrivastine Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Acrivastine Capsules Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Acrivastine Capsules Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Acrivastine Capsules Sales Value by Type
  10. 4.3.1 Global Acrivastine Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Acrivastine Capsules Sales Value by Type (2021-2032)
  12. 4.3.3 Global Acrivastine Capsules Sales Value Share by Type (2021-2032)
5 Acrivastine Capsules Market by Application
  1. 5.1 Acrivastine Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Acrivastine Capsules Sales Volume by Application
  5. 5.2.1 Global Acrivastine Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Acrivastine Capsules Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Acrivastine Capsules Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Acrivastine Capsules Sales Value by Application
  9. 5.3.1 Global Acrivastine Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Acrivastine Capsules Sales Value by Application (2021-2032)
  11. 5.3.3 Global Acrivastine Capsules Sales Value Share by Application (2021-2032)
6 Acrivastine Capsules Regional Sales and Value Analysis
  1. 6.1 Global Acrivastine Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acrivastine Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Acrivastine Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Acrivastine Capsules Sales by Region (2027-2032)
  5. 6.3 Global Acrivastine Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Acrivastine Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Acrivastine Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Acrivastine Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Acrivastine Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Acrivastine Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Acrivastine Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Acrivastine Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Acrivastine Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Acrivastine Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Acrivastine Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Acrivastine Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Acrivastine Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Acrivastine Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Acrivastine Capsules Sales Value Share by Country, 2025 VS 2032
7 Acrivastine Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Acrivastine Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acrivastine Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Acrivastine Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Acrivastine Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Acrivastine Capsules Sales by Country (2027-2032)
  6. 7.4 Global Acrivastine Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Acrivastine Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Acrivastine Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Acrivastine Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Acrivastine Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Acrivastine Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Actient Pharmaceuticals
  2. 8.1.1 Actient Pharmaceuticals Company Information
  3. 8.1.2 Actient Pharmaceuticals Business Overview
  4. 8.1.3 Actient Pharmaceuticals Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Actient Pharmaceuticals Acrivastine Capsules Product Portfolio
  6. 8.1.5 Actient Pharmaceuticals Recent Developments
  7. 8.2 Benadryl
  8. 8.2.1 Benadryl Company Information
  9. 8.2.2 Benadryl Business Overview
  10. 8.2.3 Benadryl Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Benadryl Acrivastine Capsules Product Portfolio
  12. 8.2.5 Benadryl Recent Developments
  13. 8.3 Brown & Burk UK
  14. 8.3.1 Brown & Burk UK Company Information
  15. 8.3.2 Brown & Burk UK Business Overview
  16. 8.3.3 Brown & Burk UK Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Brown & Burk UK Acrivastine Capsules Product Portfolio
  18. 8.3.5 Brown & Burk UK Recent Developments
  19. 8.4 McNeil Laboratories
  20. 8.4.1 McNeil Laboratories Company Information
  21. 8.4.2 McNeil Laboratories Business Overview
  22. 8.4.3 McNeil Laboratories Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 McNeil Laboratories Acrivastine Capsules Product Portfolio
  24. 8.4.5 McNeil Laboratories Recent Developments
  25. 8.5 The Wellcome Foundation
  26. 8.5.1 The Wellcome Foundation Company Information
  27. 8.5.2 The Wellcome Foundation Business Overview
  28. 8.5.3 The Wellcome Foundation Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 The Wellcome Foundation Acrivastine Capsules Product Portfolio
  30. 8.5.5 The Wellcome Foundation Recent Developments
  31. 8.6 Chongqing Huapont Pharmaceutical
  32. 8.6.1 Chongqing Huapont Pharmaceutical Company Information
  33. 8.6.2 Chongqing Huapont Pharmaceutical Business Overview
  34. 8.6.3 Chongqing Huapont Pharmaceutical Acrivastine Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chongqing Huapont Pharmaceutical Acrivastine Capsules Product Portfolio
  36. 8.6.5 Chongqing Huapont Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Acrivastine Capsules Value Chain Analysis
  2. 9.1.1 Acrivastine Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Acrivastine Capsules Sales Mode & Process
  6. 9.2 Acrivastine Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Acrivastine Capsules Distributors
  9. 9.2.3 Acrivastine Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst